HomeAvailabilityGuidelinesOff Label UseDangersLinksBibliography

International Journal of Gynecology and Obstetrics

December 2007, Vol 99 (supplement 2)

Misoprostol dosage recommendations from an expert committee who met in Bellagio, Italy in Feb 2007.

Forward - Misoprostol for reproductive health - D. Shaw, President FIGO

Introduction - Misoprostol in obstetrics and gynecologyA. Weeks and A. Faúndes

Misoprostol: Pharmacokinetic profiles, effects on the uterus and side-effects.
        O.S. Tang, K. Gemzell-Danielsson and P.C. Ho

Cervical priming with misoprostol prior to transcervical procedures.
        C. Fiala, K. Gemzell-Danielsson, O.S. Tang and H. von Hertzen

Misoprostol for the termination of pregnancy up to 12 completed weeks of pregnancy.
        A. Faúndes, C. Fiala, O.S. Tang and A. Velasco

Misoprostol for the termination of pregnancy with a live fetus at 13 to 26 weeks.
         P.C. Ho, P.D. Blumenthal, K. Gemzell-Danielsson, R. Gómez Ponce de Leon, S. Mittal                 and O.S. Tang

Misoprostol to treat missed abortion in the first trimester.
          K. Gemzell-Danielsson, P.C. Ho, R. Gómez Ponce de León, A. Weeks and B. Winikoff

Treatment of incomplete abortion and miscarriage with misoprostol.
          J. Blum, B. Winikoff, K. Gemzell-Danielsson, P.C. Ho, R. Schiavon and A. Weeks

Misoprostol for intrauterine fetal death.
          R. Gómez Ponce de León, D. Wing and C. Fiala

Misoprostol for induction of labor with a live fetus.
          A. Weeks, Z. Alfirevic, A. Faúndes, G.J. Hofmeyr, P. Safar and D. Wing

Prevention of postpartum hemorrhage with misoprostol.
          Z. Alfirevic, J. Blum, G. Walraven, A. Weeks and B. Winikoff

Treatment of postpartum hemorrhage with misoprostol.
          J. Blum, Z. Alfirevic, G. Walraven, A. Weeks and B. Winikoff